Abstract:4343 Many cancer cells exhibit mitochondrial respiratory dysfunction due to multiple factors including mitochondrial DNA (mtDNA) mutations, hypoxia in tumor tissues, and oncogenic signals. An important consequence of mitochondrial respiration defect in cancer cells is a decrease of ATP generation in the mitochondria and an increase of aerobic glycolysis in the cytosol (the Warburg effect). However, the precise relationship between mitochondrial dysfunction and cancer cell survival remain elusive, and the potential therapeutic implications remain to be investigated. To study underlying mechanisms and test new therapeutic approaches, a novel model system harboring a dominant negative form of mitochondrial DNA polymerase gamma (POLGdn) was expressed in the T-ReX293 tetracycline inducible cell system (tet/on system). Mitochondrial dysfunctions, including a significant decrease in mtDNA content, mtDNA-encoded RNA/protein expression, and oxygen consumption, were observed upon POLGdn expression (tet/on). Increased glycolysis was also observed, as evidenced by elevated glucose uptake, lactate production, and HKII protein expression. Importantly, NOX activation was observed in this model system two days after POLGdn expression. Detail analysis revealed an increased expression of NOXA1 and p47, associated with an increase in NOX activity and increased ROS generation compared with the non-induced (tet/off) cells. Upon treatment of the cells with DPI, a NOX inhibitor, tet/on cells exhibited a decrease in glucose uptake and ATP level, but showed a slight increase in lactate production. In contrast, the tet/off cells showed no change in glucose uptake and ATP level but had a significant increase in lactate production. Tet/on cells showed resistance to gemcitabine and taxol treatment, but sensitive to DPI treatment. Further analysis by comparing immortalized ovarian epithelial T72 cells with the Ras transformed tumorigenic T72-Ras cells showed that the transformed cells had increased NOX activity, increased gene expression of NOX1, NOX2 and p47, and more sensitive to DPI treatment especially under hypoxic condition while mitochondrial respiration was suppressed. These data together suggest that mitochondrial dysfunction leads to NOX activation, and that NOX inhibition might have potential implications in cancer therapeutics.

The Association between NADPH Oxidase 2 (NOX2) and Drug Resistance in Cancer

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of Acute Myeloid Leukemias

NOX2-Derived Reactive Oxygen Species in Cancer

The Role of NADPH Oxidase 2 in Normal and Malignant Hematopoiesis

The Association Between NADPH Oxidase (NOX) Polymorphisms with Immunohistochemistry and Survival in Diffuse Large B Cell Lymphoma Patients

Novel Role of Nox in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and As A Potential Target for Cancer Therapy

The Emerging Roles of Nitric Oxide in Ferroptosis and Pyroptosis of Tumor Cells.

NADPH Oxidase 2 Has a Crucial Role in Cell Cycle Progression of Esophageal Squamous Cell Carcinoma

NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy

NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells

Thioredoxin Activity Confers Resistance Against Oxidative Stress In Tumor-Infiltrating Nk Cells

Mitochondrial Dysfunction Leads to NADPH Oxidase (NOX) Activation and Sensitization of Cancer Cells to NOX Inhibitor

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role

The development of NOX family proteins

Tumoral NOX4 Recruits M2 Tumor-Associated Macrophages Via ROS/PI3K Signaling-Dependent Various Cytokine Production to Promote NSCLC Growth.

Structure, Activation, and Regulation of NOX2: At the Crossroad between the Innate Immunity and Oxidative Stress-Mediated Pathologies

Prognostic value of NOX2 as a potential biomarker for lung adenocarcinoma using TCGA and clinical validation

NOX4 Supports Glycolysis and Promotes Glutamine Metabolism in Non-Small Cell Lung Cancer Cells.

NADPH oxidases: an overview from structure to innate immunity-associated pathologies

Modulating ROS to Overcome Multidrug Resistance in Cancer.